Medicare
Commentary
Executive Order On Drug Price Controls Would Backfire
Rumor has it that President Trump will soon issue a sweeping executive order to lower prescription drug prices by fiat. Nothing is set in stone. But the order would reportedly index the government’s reimbursements for medicines to the prices that Britain, France, Canada, and other developed nations pay. Since all those nations ...
Commentary
Biden a moderate? Sanders, AOC plans for candidate suggest this instead
Presumptive Democratic presidential nominee Joe Biden has long been considered a political moderate. A new report from his “unity” task forces should put that reputation to rest. The 110-page document offers detailed policy recommendations for an incoming Biden administration. It would represent the most left-wing governing program of any president ...
Commentary
Will COVID-19 launch an epidemic of cancer?
With coronavirus cases spiking, Texas Gov. Greg Abbott has issued an order halting the state’s reopening and banning elective procedures in hot-spot counties. As more states see viral outbreaks, many governors will be tempted to follow Gov. Abbott’s example. But COVID-19 is not the only threat to public health. Millions ...
Commentary
Reforms Should Empower Healthcare Entrepreneurs Not Bureaucrats
Unaffordable healthcare is an unnecessary access barrier that has burdened too many people with financially ruinous debt. Worsening these outcomes, healthcare waste is excessive, and productivity is stagnating. In response, more and more policymakers are favoring reforms that would nationalize healthcare or create a public health insurance option. Further socializing ...
Commentary
Expand Medicaid? Democrats’ plan would increase waste, fraud and debt
If Democrats can’t get “Medicare-for-all,” it seems they’ll settle for “Medicaid-for-most.” Last month, the House of Representatives passed a bill that would supposedly “stabilize” ObamaCare by lavishing billions of dollars on Medicaid. To pay for that effort, the bill’s proponents envision cutting Medicare by nearly $450 billion over 10 years. Democrats are also lobbying states to expand the program to able-bodied, ...
Commentary
Telehealth’s Success During COVID-19 Shows Need to Empower Health Care Innovators
The COVID-19 crisis has tested America’s health care system like no other event in recent memory. One irony during this pandemic is that America has actually experienced the promise of health care innovation in an important way, namely through telehealth. Telehealth allows patients to talk with their doctors online using ...
Commentary
Learning The Right Lessons From The Race For An Effective Covid-19 Treatment
On June 29, 2020 Gilead announced its price for remdesivir – an antiviral medication that has shown efficacy shortening the recovery time for patients with Covid-19. This price announcement provides several important lessons for the U.S. healthcare system. First, and perhaps most important, innovation is essential for winning the war against Covid-19. ...
Commentary
Democrats’ Obamacare Bailout Could Extend The Pandemic
This week, the House of Representatives is set to vote on legislation designed to “stabilize” Obamacare. Democrats claim the plan, which extends exchange subsidies to a broader share of the population, will help more Americans afford health insurance in the midst of the pandemic and accompanying economic crisis. But the legislation would ...
Business & Economics
NEW STUDY: Future Medical Innovation Will Be Hindered Unless Elected Officials Embrace Health Care Entrepreneurship
As Americans have benefited from tele-health and other innovations thanks to COVID-19 regulatory relief, future medical advances will be stymied unless policymakers remove road blocks that make it difficult for entrepreneurs to develop new technology and for patients to access it, finds the latest study in the Breaking Down Barriers ...
Commentary
Price controls punish U.S. innovators and economy
America’s biopharmaceutical industry dwarfs most other economic sectors. It’s one of our nation’s single biggest job creators, supporting close to a million positions across the country. And its products save countless lives each year. Yet for some reason, politicians in both parties seem determined to snuff it out by imposing ...
Executive Order On Drug Price Controls Would Backfire
Rumor has it that President Trump will soon issue a sweeping executive order to lower prescription drug prices by fiat. Nothing is set in stone. But the order would reportedly index the government’s reimbursements for medicines to the prices that Britain, France, Canada, and other developed nations pay. Since all those nations ...
Biden a moderate? Sanders, AOC plans for candidate suggest this instead
Presumptive Democratic presidential nominee Joe Biden has long been considered a political moderate. A new report from his “unity” task forces should put that reputation to rest. The 110-page document offers detailed policy recommendations for an incoming Biden administration. It would represent the most left-wing governing program of any president ...
Will COVID-19 launch an epidemic of cancer?
With coronavirus cases spiking, Texas Gov. Greg Abbott has issued an order halting the state’s reopening and banning elective procedures in hot-spot counties. As more states see viral outbreaks, many governors will be tempted to follow Gov. Abbott’s example. But COVID-19 is not the only threat to public health. Millions ...
Reforms Should Empower Healthcare Entrepreneurs Not Bureaucrats
Unaffordable healthcare is an unnecessary access barrier that has burdened too many people with financially ruinous debt. Worsening these outcomes, healthcare waste is excessive, and productivity is stagnating. In response, more and more policymakers are favoring reforms that would nationalize healthcare or create a public health insurance option. Further socializing ...
Expand Medicaid? Democrats’ plan would increase waste, fraud and debt
If Democrats can’t get “Medicare-for-all,” it seems they’ll settle for “Medicaid-for-most.” Last month, the House of Representatives passed a bill that would supposedly “stabilize” ObamaCare by lavishing billions of dollars on Medicaid. To pay for that effort, the bill’s proponents envision cutting Medicare by nearly $450 billion over 10 years. Democrats are also lobbying states to expand the program to able-bodied, ...
Telehealth’s Success During COVID-19 Shows Need to Empower Health Care Innovators
The COVID-19 crisis has tested America’s health care system like no other event in recent memory. One irony during this pandemic is that America has actually experienced the promise of health care innovation in an important way, namely through telehealth. Telehealth allows patients to talk with their doctors online using ...
Learning The Right Lessons From The Race For An Effective Covid-19 Treatment
On June 29, 2020 Gilead announced its price for remdesivir – an antiviral medication that has shown efficacy shortening the recovery time for patients with Covid-19. This price announcement provides several important lessons for the U.S. healthcare system. First, and perhaps most important, innovation is essential for winning the war against Covid-19. ...
Democrats’ Obamacare Bailout Could Extend The Pandemic
This week, the House of Representatives is set to vote on legislation designed to “stabilize” Obamacare. Democrats claim the plan, which extends exchange subsidies to a broader share of the population, will help more Americans afford health insurance in the midst of the pandemic and accompanying economic crisis. But the legislation would ...
NEW STUDY: Future Medical Innovation Will Be Hindered Unless Elected Officials Embrace Health Care Entrepreneurship
As Americans have benefited from tele-health and other innovations thanks to COVID-19 regulatory relief, future medical advances will be stymied unless policymakers remove road blocks that make it difficult for entrepreneurs to develop new technology and for patients to access it, finds the latest study in the Breaking Down Barriers ...
Price controls punish U.S. innovators and economy
America’s biopharmaceutical industry dwarfs most other economic sectors. It’s one of our nation’s single biggest job creators, supporting close to a million positions across the country. And its products save countless lives each year. Yet for some reason, politicians in both parties seem determined to snuff it out by imposing ...
